Samil Pharmaceutical Co Ltd banner
S

Samil Pharmaceutical Co Ltd
KRX:000520

Watchlist Manager
Samil Pharmaceutical Co Ltd
KRX:000520
Watchlist
Price: 10 020 KRW -2.34% Market Closed
Market Cap: ₩217.3B

Balance Sheet

Balance Sheet Decomposition
Samil Pharmaceutical Co Ltd

Balance Sheet
Samil Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
3 176
6 163
12 306
10 093
8 155
10 381
4 316
6 374
489
1 860
4 160
13 395
23 363
1 284
3 410
6 167
991
2 989
16 719
15 998
3 992
1 903
906
5 137
Cash
0
0
0
0
0
0
0
0
93
0
0
0
21
16
0
0
52
27
61
53
43
33
23
23
Cash Equivalents
3 176
6 163
12 306
10 093
8 155
10 381
4 316
6 374
582
1 860
4 160
13 395
23 342
1 268
3 410
6 167
939
2 962
16 658
15 945
3 949
1 871
884
5 114
Short-Term Investments
11 912
11 712
5 938
5 743
7 019
4 850
4 327
3 532
16 683
7 820
443
55
0
10 000
2 000
2 000
0
8 000
13 054
1 217
11 269
62
23
4
Total Receivables
12 549
13 509
14 286
15 820
20 690
23 820
22 739
26 438
30 917
31 143
26 767
29 720
33 365
34 240
35 626
34 880
32 927
23 447
26 273
30 195
31 374
34 304
35 900
35 779
Accounts Receivables
12 546
13 508
14 285
15 541
20 607
23 622
22 387
25 155
29 582
30 432
26 581
24 670
26 760
29 131
35 626
34 880
32 808
23 368
25 823
30 139
31 077
34 181
35 813
35 025
Other Receivables
3
1
1
279
83
198
352
1 283
1 335
711
186
5 050
6 605
5 109
0
0
119
79
450
56
297
124
87
755
Inventory
8 393
13 625
11 384
12 820
13 399
15 190
17 143
20 791
16 877
22 340
23 738
17 534
15 635
15 500
14 475
11 338
16 466
23 878
22 413
24 084
24 177
24 742
32 511
34 770
Other Current Assets
104
1 501
324
203
2 078
1 065
376
724
880
1 572
1 219
790
458
501
405
1 573
1 776
870
742
1 031
5 899
13 769
11 775
15 655
Total Current Assets
36 134
46 510
44 238
44 679
51 341
55 305
48 901
57 858
65 847
64 734
56 326
61 494
72 821
61 525
55 917
55 958
52 160
59 184
79 200
72 523
76 711
74 781
81 115
91 346
PP&E Net
9 487
9 804
10 967
17 983
17 919
24 303
30 583
46 097
43 337
35 347
37 222
36 128
35 258
39 416
38 450
39 215
71 893
62 349
71 902
64 808
103 394
233 946
242 198
252 893
PP&E Gross
9 487
9 804
10 967
17 983
17 919
24 303
30 583
46 097
43 337
35 347
37 222
36 128
35 258
39 416
0
0
71 893
62 349
71 902
64 808
103 394
233 946
242 198
252 893
Accumulated Depreciation
14 734
14 991
17 127
19 087
20 928
22 854
24 744
28 179
27 114
23 039
25 558
28 503
31 197
33 000
0
0
40 858
43 756
47 017
48 519
52 189
52 576
55 408
59 184
Intangible Assets
40
33
25
16
69
687
537
389
1 921
8 670
6 789
6 354
5 051
1 997
2 008
2 055
1 567
1 572
1 731
1 726
1 295
3 136
2 819
5 512
Note Receivable
0
0
0
0
0
0
0
0
35
35
35
624
510
0
1 804
2 109
0
0
0
0
0
0
0
1 033
Long-Term Investments
2 122
1 611
2 593
3 086
3 754
4 158
6 783
8 804
8 964
23 731
18 889
4 351
104
2 777
1 089
1 087
8 656
18 360
19 088
39 675
39 099
38 177
37 770
37 335
Other Long-Term Assets
2 027
2 763
4 450
4 359
5 186
8 137
8 809
9 478
8 846
1 596
1 941
2 045
1 966
2 576
45
572
1 201
6 484
11 954
12 929
5 907
6 660
6 778
6 952
Total Assets
49 809
N/A
60 722
+22%
62 273
+3%
70 122
+13%
78 268
+12%
92 590
+18%
95 615
+3%
122 627
+28%
128 950
+5%
134 114
+4%
121 203
-10%
110 996
-8%
115 709
+4%
108 291
-6%
99 312
-8%
100 995
+2%
135 477
+34%
147 949
+9%
183 875
+24%
191 661
+4%
226 405
+18%
356 700
+58%
370 680
+4%
395 071
+7%
Liabilities
Accounts Payable
2 375
4 473
2 168
2 786
4 408
9 983
11 091
12 343
13 310
8 282
7 043
6 900
5 973
5 922
10 766
11 707
9 014
9 236
9 130
10 826
8 541
13 660
21 004
19 159
Accrued Liabilities
667
199
913
643
1 155
864
1 885
1 020
1 570
2 218
2 467
2 738
2 371
2 511
0
0
3 155
2 653
3 807
4 727
4 877
21 852
8 260
8 812
Short-Term Debt
6 700
6 700
6 700
6 700
5 000
2 500
3 612
16 465
15 762
19 617
35 314
23 000
26 000
28 200
28 200
28 200
34 200
66 709
47 545
30 084
50 133
36 077
36 850
50 429
Current Portion of Long-Term Debt
267
231
48
0
0
0
0
444
7 538
8 290
0
0
0
0
0
0
0
0
807
44 012
42 468
49 877
88 236
13 604
Other Current Liabilities
6 108
7 345
4 856
8 023
8 434
12 779
10 628
8 379
7 209
5 351
5 217
4 261
8 441
4 511
2 658
3 283
6 043
6 723
6 868
9 035
15 655
11 126
14 326
14 656
Total Current Liabilities
16 117
18 948
14 685
18 153
18 997
26 126
27 216
38 650
45 388
43 757
50 042
36 899
42 786
41 144
41 624
43 191
52 412
85 320
68 156
98 684
121 674
132 592
168 675
106 660
Long-Term Debt
279
48
0
0
0
0
0
15 870
8 290
10 000
0
7 000
0
8 000
0
2 000
27 000
0
45 280
20 307
32 914
73 304
50 794
86 048
Deferred Income Tax
1 113
1 875
2 273
2 241
2 257
2 098
578
0
374
2 332
1 004
706
509
0
0
0
0
0
0
0
0
13 172
9 752
7 493
Other Liabilities
1 118
1 687
2 032
1 965
2 331
2 457
2 564
4 500
5 183
3 131
3 553
3 518
2 387
3 732
3 277
2 934
4 898
6 546
8 166
9 119
6 070
11 812
13 632
18 746
Total Liabilities
18 627
N/A
22 557
+21%
18 991
-16%
22 358
+18%
23 586
+5%
30 681
+30%
30 359
-1%
59 020
+94%
59 235
+0%
59 221
0%
54 599
-8%
48 122
-12%
45 682
-5%
52 876
+16%
44 902
-15%
48 125
+7%
84 310
+75%
91 866
+9%
121 602
+32%
128 110
+5%
160 658
+25%
230 881
+44%
242 853
+5%
218 947
-10%
Equity
Common Stock
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
6 500
6 500
6 695
6 769
6 857
7 613
10 846
Retained Earnings
25 678
32 660
37 778
42 259
49 143
56 446
60 336
60 435
66 409
70 967
62 978
59 257
66 397
52 749
51 472
49 932
48 229
36 468
35 216
35 034
27 741
26 605
28 019
19 937
Additional Paid In Capital
4
4
4
4
4
4
4
4
4
0
0
4
4
4
4
4
4
15 977
23 168
26 755
35 252
40 485
44 011
83 146
Unrealized Security Profit/Loss
0
0
0
0
35
0
0
0
0
4
4
10
4
272
0
0
0
0
0
240
141
50 924
49 312
49 254
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
1 878
2 565
0
0
0
0
0
3 765
5 431
4 142
4 161
2 517
Other Equity
0
0
0
0
0
41
584
2 332
2 197
1 577
1 878
1 878
0
0
2 565
2 565
2 565
2 863
2 611
928
1 557
5 091
3 033
15 458
Total Equity
31 182
N/A
38 164
+22%
43 282
+13%
47 763
+10%
54 682
+14%
61 910
+13%
65 256
+5%
63 607
-3%
69 715
+10%
74 893
+7%
66 604
-11%
62 874
-6%
70 027
+11%
55 415
-21%
54 410
-2%
52 871
-3%
51 167
-3%
56 083
+10%
62 272
+11%
63 551
+2%
65 746
+3%
125 820
+91%
127 827
+2%
176 124
+38%
Total Liabilities & Equity
49 809
N/A
60 722
+22%
62 273
+3%
70 122
+13%
78 268
+12%
92 590
+18%
95 615
+3%
122 627
+28%
128 950
+5%
134 114
+4%
121 203
-10%
110 996
-8%
115 709
+4%
108 291
-6%
99 312
-8%
100 995
+2%
135 477
+34%
147 949
+9%
183 875
+24%
191 661
+4%
226 405
+18%
356 700
+58%
370 680
+4%
395 071
+7%
Shares Outstanding
Common Shares Outstanding
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
12
12
13
14
14
14
21
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett